Outcomes in children with vesicoureteral reflux receiving antibiotic prophylaxis

Madeline G Tompkins1, Michelle Kussin1,2, John C Christenson2

  • 1Department of Pharmacy, Riley Hospital for Children at Indiana University Health, Indianapolis, IN, USA.

Insights

Antibiotic prophylaxis for pediatric vesicoureteral reflux (VUR) is debated. Prophylaxis showed limited success, with 57% of patients experiencing recurrent urinary tract infections (UTIs), often caused by resistant bacteria.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Urology

Background:

  • Vesicoureteral reflux (VUR) in children is a common condition.
  • The use of antibiotic prophylaxis to prevent recurrent urinary tract infections (UTIs) in these patients is controversial.
  • Understanding the efficacy of prophylaxis is crucial for clinical decision-making.

Purpose of the Study:

  • To evaluate the effectiveness of antibiotic prophylaxis in children diagnosed with VUR after an initial UTI.
  • To analyze the rate of recurrent UTIs in patients receiving prophylaxis.
  • To identify the pathogens involved in UTI recurrences.

Main Methods:

  • Retrospective review of pediatric patients diagnosed with VUR.
  • Analysis of patients who received antibiotic prophylaxis post-index UTI.
  • Comparison of recurrent UTI rates between patients with and without urologic anomalies.
  • Identification of causative organisms in recurrent UTIs.

Main Results:

  • A significant rate of recurrent UTIs was observed in children on antibiotic prophylaxis for VUR.
  • Recurrent UTIs occurred in 57% of patients with urologic anomalies and 33% without.
  • Multidrug-resistant organisms were responsible for 25% of first UTI recurrences.

Conclusions:

  • Antibiotic prophylaxis for VUR in children may have limited efficacy in preventing recurrent UTIs.
  • The emergence of multidrug-resistant organisms is a concern in this patient population.
  • Further research is needed to optimize management strategies for pediatric VUR.